  |
|
|||||||||||||||||||||
   |
||||||||||||||||||||||
| About | Editorial Board | Ahead of print | Current Issue | Archive | Search | Instructions | Announcement | Etcetera | Contact | Advertise |
|
|||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||
|
 Reader
Comments
Year : 2020 | Volume: 52 | Issue Number: 3 POTENTIAL PHARMACOLOGICAL TARGETSTarget/therapies for chronic recurrent erythema nodosum leprosum Thangaraju Pugazhenthan, Varthya Shoban Babu, Venkatesan Sajitha
|
||||||||||||||
|
|
| Online since 20th July '04 | |
| Published by Wolters Kluwer - Medknow |
